Linajust M (2.5/500) ( Linagliptin & Metformin Hydrochloride (2.5mg/500mg))

Linajust M (2.5/500) combines Linagliptin (2.5 mg) and Metformin Hydrochloride (500 mg) to effectively manage blood sugar levels in adults with type 2 diabetes. Linagliptin a DPP-4 inhibitor enhances incretin levels promoting insulin release and reducing glucagon secretion. Metformin works by decreasing hepatic glucose production and improving insulin sensitivity. This combination therapy not only helps control blood glucose but also aids in weight management making it a valuable option for comprehensive diabetes care.